CHRYSTAL JOY JURADO: Open Payments
NPI 1023635513 · HAYWARD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,588 in 72 payments from 20 companies in 2025. Trend: 2023 $464 · 2024 $1,229 · 2025 $1,588
Food & beverage: $1,588
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 10 | $246 |
| Novo Nordisk Inc | 11 | $221 |
| AstraZeneca Pharmaceuticals LP | 9 | $174 |
| ABBVIE INC. | 9 | $171 |
| GlaxoSmithKline, LLC. | 5 | $115 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $107 |
| Otsuka America Pharmaceutical, Inc. | 4 | $72 |
| Kowa Pharmaceuticals America, Inc. | 4 | $69 |
| Astellas Pharma US Inc | 2 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $55 |
Products named: MOUNJARO, VRAYLAR, AIRSUPRA, CAPLYTA, Wegovy, JARDIANCE, AREXVY, REXULTI.
Industry payments across CA — which companies pay providers there.
